on condition that ATMPs—along with the individual journeys associated with them—are essentially different from conventional biopharmaceuticals, developing and conducting trials of these novel therapeutics includes exceptional regulatory and medical considerations. In this article, we investigate techniques for prosperous commence-up and executi